It's long on the daily

$DOGEUSD - Chart Link-

great idea,  in the meantime for active trades you have original date of entry great idea!!, please change the dates   of those ETF's that are flat with today's date and enter the date that it went flat.  It would be very helpful to notice at a glance when the ETF went flat.  keep up the good work

GXLM short today.

https://stockcharts.com/h-sc/ui?s=GXLM&p=D&yr=0&mn=9&dy=0&id=p17475131400&a=1851087024&listNum=6

I'm going to be removing that URA 60, does too many trades, too much noise

I was having a play with URA 60 as well which may not have been the wisest on my part as got in late.  If you look at the stats trade link below it looks like the 12/3 also exited on the same day, I'm not sure what the STS was set for that one as only did the 12/5 one.

https://breakpointtrades.com/sts_premium/trades/?symbol=URA&time=60&system=1

XLU 78 and 130 the STS is all over the place it.

Probably the S&P since it was rumored they might be today. S&P would be dumb not to take them The best stock in the market. 

I am confused the URA 60 went long on Tuesday 12/3 yet it show that entry was 12/5.

There is news now but can’t seem to dig it up…secondary, non inclusion to S&P 100 ? comes to mind..stock down $27. I’m sure it will find its way back up…

good wknd community

Jeff Bezos on risk and opportunity.

https://x.com/epictrades1/status/1864451316254155040

Just wanted to wish everyone a great weekend.  We killed it this week with some awesome trades (notably the mega caps) as well as valuable input from many other members here - a big thanks.  Off to take my wife to first PT Session.  

RGTI has a gap beginning @4.82. Day chart.

SPX 10m ... another very small range day, but the skynet bots knows the drill ... try to ramp EOD ...      ...  I like to see this, looks totally organic and real ... like santa trying to bang the close  ...  

James added a button for admin where I can mark posts like this to save them into an education area that you can all access in the future. I think that's a good idea because I'll make informative educational posts like this but then they get lost in the 10s of 1000s of posts - so nice to be able to mark ones to save into a database which can be a good educational reference for you guys to look through

I still get the questions: Matt why do you run the 22 systems on both SPY and ES futures? It's because even though two are the same index , they are different prices and indicators will be at slightly different areas - thus while you will get many of the same trades, at times you get different trades, where a system triggers on SPY but not on ES and vice versa. A system may trigger on both but sometimes will enter better on one verse the other etc, and sometimes a system will trigger on one but not the other - therefore you get this 'averaging' effect

The current SPY Breakout trade that has been long almost 30 days now is a good example:  the breakout system triggered a 1 day earlier on SPY than it did on ES, thus the SPY had a better entry. Secondly - the SPY breakout is still long and is very profitable, while the ES version sold out 2 weeks ago after a short bounce off the lows, see the chart.  So if I was only running the systems on ES - you wouldn't have this nice breakout trade. And again, this goes back and forth - next time maybe the ES will catch the better price

AMZN  says it isn't seeing enough demand for AM  AI chips to offer them via its cloud

Positives:

1. Profitability Milestone:Blade achieved positive segment adjusted EBITDA in its passenger business for the trailing 12 months ending September 30, 2024, a year ahead of previous guidance.
2. Strong Financial Performance:The company reported a 27.3% year-over-year increase in flight profit and a significant rise in adjusted EBITDA, which increased more than fivefold to $4.2 million compared to the prior year.
3. Operational Efficiency:The passenger segment saw a 31% increase in flight profit, with adjusted EBITDA margins improving significantly. The restructuring in Europe and exit from unprofitable markets contributed to this efficiency.
4. Cash Flow Generation:Blade generated $6.4 million in operating cash flow and $3.7 million in free cash flow before aircraft acquisitions, indicating strong cash management.
5. Medical Segment Growth:Despite a softer quarter for organ transplants, the medical segment's adjusted EBITDA improved by 15.1%, and there was optimism about future growth driven by new partnerships and technologies.

Negatives:

1. Market Volatility:The medical segment experienced a sequential decline in revenue due to lower organ transplant volumes and increased aircraft downtime, impacting profitability.
2. Exit from Canada:The decision to exit the Western Canada market negatively impacted revenue guidance for 2025, leading to expectations of flat revenue year-over-year in the passenger segment.
3. Maintenance Challenges:Increased aircraft downtime and maintenance issues contributed to a decline in medical segment margins, highlighting operational challenges.
4. Uncertain Market Conditions:The company acknowledged potential quarter-to-quarter variability in the medical business due to the unpredictable nature of organ transplant volumes and related expenses.